Company intelligence / Profile preview

SCOPE International

Mannheim, Baden-Württemberg, Germanyscope-international.online ↗

Ownership: Private
Employees: ~230
Development stage: Other

Overview

SCOPE International has conducted over 300 studies involving more than 87,000 patients worldwide since its founding in 2000. They have extensive experience in phases IIa–IV interventional trials as well as non-interventional and post-marketing surveillance studies for pharmaceutical companies across Europe and globally.

Therapeutic areas: OtherPulmonologyNeurologyWomen's Health
Modalities: Small moleculeBiologicMedical deviceBiosimilarGeneric
Industry: Contract Research Organization

Partnerships

TransPerfect (for document management solutions)Pharmaceutical/biotech/device companies (long-term collaborations)

Beyond the preview

Go deeper on SCOPE International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SCOPE International.

Explore the full profile